IL88276A - Pharmaceutical compositions containing b cell growth inhibitory factor for the inhibition of neoplastic cells - Google Patents

Pharmaceutical compositions containing b cell growth inhibitory factor for the inhibition of neoplastic cells

Info

Publication number
IL88276A
IL88276A IL88276A IL8827688A IL88276A IL 88276 A IL88276 A IL 88276A IL 88276 A IL88276 A IL 88276A IL 8827688 A IL8827688 A IL 8827688A IL 88276 A IL88276 A IL 88276A
Authority
IL
Israel
Prior art keywords
inhibition
pharmaceutical compositions
cell growth
compositions containing
growth inhibitory
Prior art date
Application number
IL88276A
Other languages
English (en)
Other versions
IL88276A0 (en
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of IL88276A0 publication Critical patent/IL88276A0/xx
Publication of IL88276A publication Critical patent/IL88276A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL88276A 1987-11-06 1988-11-03 Pharmaceutical compositions containing b cell growth inhibitory factor for the inhibition of neoplastic cells IL88276A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11818587A 1987-11-06 1987-11-06

Publications (2)

Publication Number Publication Date
IL88276A0 IL88276A0 (en) 1989-06-30
IL88276A true IL88276A (en) 1993-08-18

Family

ID=22377016

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88276A IL88276A (en) 1987-11-06 1988-11-03 Pharmaceutical compositions containing b cell growth inhibitory factor for the inhibition of neoplastic cells

Country Status (12)

Country Link
EP (1) EP0315289A3 (xx)
JP (1) JPH0272869A (xx)
KR (1) KR910002520B1 (xx)
CN (1) CN1040926A (xx)
AU (1) AU629185B2 (xx)
DK (1) DK618188A (xx)
FI (1) FI885055A (xx)
IL (1) IL88276A (xx)
NO (1) NO884943L (xx)
NZ (1) NZ226799A (xx)
PT (1) PT88943A (xx)
ZA (1) ZA888269B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352743A (en) * 1990-01-16 1994-10-04 Mobil Oil Corporation Solid elastomeric block copolymers
US5916871A (en) * 1992-04-27 1999-06-29 Kansas State University Research Foundation Inhibitory factor
EP0638126A4 (en) * 1992-04-27 1995-10-25 Univ Kansas State INHIBITORIC FACTOR.
WO2000075316A1 (en) * 1999-06-02 2000-12-14 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
WO2000055319A1 (en) * 1999-03-12 2000-09-21 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
WO1997037017A1 (fr) * 1996-03-29 1997-10-09 JAPAN, represented by DIRECTOR GENERAL OF NATIONAL INSTITUTE OF HEALTH SCIENCES Facteurs cytostatiques
WO2001049715A2 (en) * 2000-01-06 2001-07-12 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
IL142088A0 (en) * 1998-10-13 2002-03-10 Genentech Inc Methods and compositions for inhibiting neoplastic cell growth
JP2002531092A (ja) * 1998-12-01 2002-09-24 ジェネンテック・インコーポレーテッド 腫瘍性細胞成長阻害のための組成物及び方法
EP1820859B9 (en) * 1998-12-22 2009-10-28 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
ATE432987T1 (de) * 1998-12-22 2009-06-15 Genentech Inc Verfahren und zusammensetzungen zur hemmung des neoplastischen zellenwachstums
AU2399300A (en) * 1999-03-08 2000-09-28 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
EP1867719A3 (en) * 1999-06-02 2008-03-19 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
AU3246100A (en) * 1999-06-02 2000-12-28 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth
ATE357518T1 (de) * 1999-06-02 2007-04-15 Genentech Inc Verfahren und zusammensetzungen zur inhibierung des neoplastischen zellwachstums

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816440A (en) * 1985-09-26 1989-03-28 Cetus Corporation Stable formulation of biologically active proteins for parenteral injection
DE3688671T3 (de) * 1985-10-14 2001-05-03 Yeda Research And Development Co., Ltd. Menschliches Interferon-beta2A ; Vektoren, die Gene enthalten, die für das genannte Interferon kodieren; Zellinien, die dieses produzieren und Verwendung des genannten Interferons als Pharmazeutikum.
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
IE67035B1 (en) * 1986-07-08 1996-02-21 Genetics Inst Production and use of non-glycosylated IL-6
EP0257406B2 (en) * 1986-08-06 1998-08-12 Ajinomoto Co., Inc. Recombinant B-cell differentiation factor
SE8701004D0 (sv) * 1987-03-11 1987-03-11 Astra Ab Method for therapy of leukemias and certain other malignancies

Also Published As

Publication number Publication date
JPH0272869A (ja) 1990-03-13
FI885055A0 (fi) 1988-11-02
AU2474088A (en) 1989-05-11
NO884943D0 (no) 1988-11-04
AU629185B2 (en) 1992-10-01
KR910002520B1 (ko) 1991-04-23
DK618188D0 (da) 1988-11-04
EP0315289A3 (en) 1990-04-11
DK618188A (da) 1989-05-07
NO884943L (no) 1989-05-08
EP0315289A2 (en) 1989-05-10
KR890007751A (ko) 1989-07-05
ZA888269B (en) 1989-07-26
NZ226799A (en) 1991-08-27
PT88943A (pt) 1989-11-30
CN1040926A (zh) 1990-04-04
FI885055A (fi) 1989-05-07
IL88276A0 (en) 1989-06-30

Similar Documents

Publication Publication Date Title
GB8816437D0 (en) Cell growth inhibitory substance
AU4447093A (en) Anti-sense regulation of the genotype of plant cells
IL88276A (en) Pharmaceutical compositions containing b cell growth inhibitory factor for the inhibition of neoplastic cells
EP0159276A3 (en) Substantially purified tumor growth inhibitory factor (tif)
AU6749487A (en) Aids treatment by inhibition of cell derived cytotoxic factors
AU556704B2 (en) Plant growing cell set
GB2134134B (en) Novel cell lines for use in the preparation of hybridoma cells
IL84045A0 (en) 4-aryl-n-(2-(dialkylamino and heterocyclicamino)-alkyl)-1-piperazinecarboxamides and pharmaceutical compositions containing them
GB2210385B (en) Cell culture vial
DE3661117D1 (en) Agent for the regulation of plant growth
AU7448487A (en) Pharmaceutical composition for protection of brain cells
ZA854614B (en) Plant for intermediate storage of gas
AU7720487A (en) Pharmaceutical composition for protection of brain cells
GB2206883B (en) Substances for inhibiting cell growth
AU573341B2 (en) Pharmaceutical viral inhibitor from cell lines
GB2232998B (en) Medium supplement for the growth of hybridoma cells
AU5772786A (en) Seco-sterol compounds effective in inducing the differentiation of malignant cells
EP0435693A3 (en) Pharmaceutical compositions containing 3-oxygermylpropionic acid polymers for inhibiting the degeneration of cells
IL84803A0 (en) Plant defoliant compositions containing thiadiazole urea derivative and halophenyl dialkyl urea derivative and process for the preparation thereof
PT82656A (en) Process for the preparation of aducts of aluminium-amine phosphinate and of fungicidal compositions containing the same
PT82314A (en) Process for the preparation of urethane compositions
AU1831088A (en) Scale inhibition
AU7866987A (en) Compounds useful in the synthesis of 1-aziridinoalkyl nitroimidazoles
IL85734A0 (en) Pharmaceutical compositions for the treatment of malignant neoplastic cells containing a sugar derivative
PL266679A1 (en) Cell growth inhibiting agent